Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) Use in Clinical Trials Based on Clinicaltrials.gov Data

被引:0
|
作者
Shapiro, Lauren Rogak [1 ]
Basch, Ethan [2 ]
Mazza, Gina L. [1 ]
Lee, Minji K. [3 ]
Meek, Eric A. [1 ]
Ginos, Brenda [1 ]
Langlais, Blake T. [1 ]
Noble, Brie N. [1 ]
Yee, Claire [1 ]
Thanarajasingam, Gita [4 ]
Dueck, Amylou C. [1 ]
机构
[1] Mayo Clin, Dept Quantitat Hlth Sci, Scottsdale, AZ USA
[2] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC USA
[3] Mayo Clin, Dept Quantitat Hlth Sci, Rochester, MN USA
[4] Mayo Clin, Div Hematol, Rochester, MN USA
关键词
D O I
暂无
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
1041
引用
收藏
页码:S126 / S126
页数:1
相关论文
共 50 条
  • [21] Development of the National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
    Basch, Ethan
    Reeve, Bryce B.
    Mitchell, Sandra A.
    Clauser, Steven B.
    Minasian, Lori M.
    Dueck, Amylou C.
    Mendoza, Tito R.
    Hay, Jennifer
    Atkinson, Thomas M.
    Abernethy, Amy P.
    Bruner, Deborah W.
    Cleeland, Charles S.
    Sloan, Jeff A.
    Chilukuri, Ram
    Baumgartner, Paul
    Denicoff, Andrea
    St Germain, Diane
    O'Mara, Ann M.
    Chen, Alice
    Kelaghan, Joseph
    Bennett, Antonia V.
    Sit, Laura
    Rogak, Lauren
    Barz, Allison
    Paul, Diane B.
    Schrag, Deborah
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2014, 106 (09):
  • [22] Incorporating Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) into Dose Review in a Phase I Clinical Trial
    Mead-Harvey, Carolyn
    Noble, Brie N.
    Yee, Claire
    Mazza, Gina L.
    Langlais, Blake
    Patel, Sheetal
    Trask, Peter
    Rogak, Lauren
    Basch, Ethan
    Dueck, Amylou C.
    Thanarajasingam, Gita
    BLOOD, 2024, 144 : 2299 - 2300
  • [23] Feasibility Assessment of Using the Complete Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) Item Library
    Shepshelovich, Daniel
    McDonald, Kate
    Spreafico, Anna
    Razak, Albiruni R. A.
    Bedard, Philippe L.
    Siu, Lillian L.
    Minasian, Lori
    Hansen, Aaron R.
    ONCOLOGIST, 2019, 24 (04): : E146 - E148
  • [24] Cultural adaptation of the Italian version o the Patient-Reported Outcomes Common Terminology Criteria for Adverse Event (PRO-CTCAE®)
    Caminiti, Caterina
    Bryce, Jane
    Riva, Silvia
    Ng, Diane
    Diodati, Francesca
    Iezzi, Elisa
    Sparavigna, Lucia
    Novello, Silvia
    Porta, Camillo
    Del Mastro, Lucia
    Procopio, Giuseppe
    Cinieri, Saverio
    Falzetta, Amalia
    Calabro, Fabio
    Lorusso, Vito
    Cogoni, Alessio Aligi
    Tortora, Giampaolo
    Maruzzo, Marco
    Passalacqua, Rodolfo
    Cognetti, Francesco
    Adamo, Vincenzo
    Capelletto, Enrica
    Ferrari, Alessandra
    Bagnalasta, Michela
    Bassi, Maurizio
    Nicelli, Annalisa
    De Persis, Davide
    D'Acunti, Alessia
    Iannelli, Elisabetta
    Perrone, Francesco
    Mitchell, Sandra A.
    TUMORI JOURNAL, 2023, 109 (03): : 324 - 334
  • [25] CAPTURING SYMPTOM BURDEN AND TREATMENT TOLERABILITY IN CANCER CLINICAL TRIALS: NCI'S PATIENT-REPORTED OUTCOMES VERSION OF THE COMMON TERMINOLOGY CRITERIA FOR ADVERSE EVENTS (PRO-CTCAE)
    Mitchell, Sandra
    Castro, Kathleen
    St Germain, Diane
    Denicoff, Andrea
    Watkins-Bruner, Deborah
    O'Mara, Ann
    ONCOLOGY NURSING FORUM, 2013, 40 (06) : E454 - E454
  • [26] Linguistic validation of the Spanish version of the National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
    Benjamin Arnold
    Sandra A. Mitchell
    Lauren Lent
    Tito R. Mendoza
    Lauren J. Rogak
    Natalie M. Barragán
    Gordon Willis
    Mauricio Medina
    Suzanne Lechner
    Frank J. Penedo
    Jay K. Harness
    Ethan M. Basch
    Supportive Care in Cancer, 2016, 24 : 2843 - 2851
  • [27] Patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE): emerging developments and practical approaches to collection and analysis of pro-based symptomatic adverse event data in cancer clinical trials
    Mitchell, Sandra A.
    Basch, Ethan
    Walding, Andrew S.
    Dueck, Amylou C.
    QUALITY OF LIFE RESEARCH, 2016, 25 : 5 - 5
  • [28] Linguistic validation of the Spanish version of the National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
    Arnold, Benjamin
    Mitchell, Sandra A.
    Lent, Lauren
    Mendoza, Tito R.
    Rogak, Lauren J.
    Barragan, Natalie M.
    Willis, Gordon
    Medina, Mauricio
    Lechner, Suzanne
    Penedo, Frank J.
    Harness, Jay K.
    Basch, Ethan M.
    SUPPORTIVE CARE IN CANCER, 2016, 24 (07) : 2843 - 2851
  • [29] Stakeholder perspectives on implementing the National Cancer Institute's patient-reported outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
    Bruner, Deborah Watkins
    Hanisch, Laura J.
    Reeve, Bryce B.
    Trotti, Andy M.
    Schrag, Deborah
    Sit, Laura
    Mendoza, Tito R.
    Minasian, Lori
    O'Mara, Ann
    Denicoff, Andrea M.
    Rowland, Julia H.
    Montello, Michael
    Geoghegan, Cindy
    Abernethy, Amy P.
    Clauser, Steven B.
    Castro, Kathleen
    Mitchell, Sandra A.
    Burke, Laurie
    Trentacosti, Ann Marie
    Basch, Ethan M.
    TRANSLATIONAL BEHAVIORAL MEDICINE, 2011, 1 (01) : 110 - 122
  • [30] Feasibility of an electronic patient-reported outcome intervention based on the patient-reported outcomes version of common terminology criteria for adverse events ( PRO-CTCAE) in Danish prostate cancer patients
    Baeksted, Christina
    Pappot, Helle
    Nissen, Aase
    Hjollund, Niels Henrik
    Mitchell, Sandra A.
    Basch, Ethan
    Bidstrup, Pernille E.
    Dalton, Susanne O.
    Johansen, Christoffer
    QUALITY OF LIFE RESEARCH, 2016, 25 : 40 - 40